JP5432122B2 - カカオ抽出物の使用 - Google Patents

カカオ抽出物の使用 Download PDF

Info

Publication number
JP5432122B2
JP5432122B2 JP2010504545A JP2010504545A JP5432122B2 JP 5432122 B2 JP5432122 B2 JP 5432122B2 JP 2010504545 A JP2010504545 A JP 2010504545A JP 2010504545 A JP2010504545 A JP 2010504545A JP 5432122 B2 JP5432122 B2 JP 5432122B2
Authority
JP
Japan
Prior art keywords
extract
cocoa
weight
present
extract according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010504545A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526036A (ja
JP2010526036A5 (cg-RX-API-DMAC7.html
Inventor
ハーウィグ バーナート，
リーン アレガート，
Original Assignee
バリー カレボー アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バリー カレボー アーゲー filed Critical バリー カレボー アーゲー
Publication of JP2010526036A publication Critical patent/JP2010526036A/ja
Publication of JP2010526036A5 publication Critical patent/JP2010526036A5/ja
Application granted granted Critical
Publication of JP5432122B2 publication Critical patent/JP5432122B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5777—Theobroma, e.g. cocao or cocoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2010504545A 2007-04-26 2008-04-24 カカオ抽出物の使用 Expired - Fee Related JP5432122B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92632807P 2007-04-26 2007-04-26
US60/926,328 2007-04-26
GBGB0719544.9A GB0719544D0 (en) 2007-10-08 2007-10-08 Cocoa extract and use thereof
GB0719544.9 2007-10-08
PCT/EP2008/003323 WO2008131911A1 (en) 2007-04-26 2008-04-24 Cocoa extract and use thereof

Publications (3)

Publication Number Publication Date
JP2010526036A JP2010526036A (ja) 2010-07-29
JP2010526036A5 JP2010526036A5 (cg-RX-API-DMAC7.html) 2011-06-16
JP5432122B2 true JP5432122B2 (ja) 2014-03-05

Family

ID=38739241

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504545A Expired - Fee Related JP5432122B2 (ja) 2007-04-26 2008-04-24 カカオ抽出物の使用

Country Status (5)

Country Link
US (1) US8597692B2 (cg-RX-API-DMAC7.html)
EP (1) EP2142203A1 (cg-RX-API-DMAC7.html)
JP (1) JP5432122B2 (cg-RX-API-DMAC7.html)
GB (1) GB0719544D0 (cg-RX-API-DMAC7.html)
WO (1) WO2008131911A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2401926T3 (es) 2006-11-17 2013-04-25 Barry Callebaut Ag Método para la producción de un producto de cacao soluble a partir de cacao en polvo
US8609174B2 (en) * 2006-11-17 2013-12-17 Barry Callebaut Ag Method for producing a soluble cocoa product from cocoa powder
GB0719545D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Novel use of cocoa extract
GB0719542D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Use of cocoa extract
GB0719543D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Cocoa extract and novel use thereof
GB0724716D0 (en) * 2007-12-19 2008-01-30 Barry Callebaut Ag Process
KR20160054015A (ko) 2009-04-03 2016-05-13 다이아나플랜트사이언스, 아이엔씨. 식물 세포 배양 유래 프로시아니딘의 생산 및 추출
BR112013008175A2 (pt) * 2010-10-04 2016-06-21 Dianaplantsciences Sas produção e extração de procianidinas de culturas celulares vegetais
JP5208326B2 (ja) * 2011-03-24 2013-06-12 株式会社明治 コーヒー飲料及びその製造方法
ITTV20120064A1 (it) * 2012-04-19 2013-10-20 R I Group Srl Estratto per trattamento delle cefalee primitive
MX371133B (es) 2012-12-20 2020-01-17 Arabian German Medical Products Co W L L Composicion que comprende raphanus, theobroma y passiflora para el tratamiento del abuso de opiaceos y alcohol.
ES2552706B1 (es) * 2014-05-29 2016-09-13 Universitat De Les Illes Balears La teobromina y sus derivados para el tratamiento o prevenciónde la litiasis renal
CN104223353B (zh) * 2014-08-19 2016-02-24 云南中烟工业有限责任公司 一种烟草发酵所得烟用香料及其应用
CN104232689A (zh) * 2014-09-30 2014-12-24 云南中烟工业有限责任公司 一种百合与烟草混合发酵制备的烟用香料及其应用
WO2023164338A2 (en) * 2022-02-23 2023-08-31 The Jonathan Hurt Living Trust Compositions and methods for the treatment of sexual dysfunctions

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU76148A1 (cg-RX-API-DMAC7.html) * 1976-11-08 1978-07-10
DE3908649A1 (de) * 1989-03-16 1990-09-20 Jacobs Suchard Ag Verfahren zur herstellung eines loeslichen kakaoerzeugnisses
FR2669537B1 (fr) 1990-11-28 1993-02-19 Oreal Composition amincissante a base d'alpha-2-bloqueurs.
PT628311E (pt) * 1992-07-08 2002-09-30 Kyowa Hakko Kogyo Kk Derivado de xantina com actividade antidepressiva
FR2708198B1 (fr) * 1993-07-28 1995-10-20 Dior Christian Parfums Composition cosmétique ou pharmaceutique, notamment dermatologique contenant un extrait de Tephrosia, en particulier Tephrosia purpurea.
US5554645A (en) 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
CN1037315C (zh) * 1995-03-24 1998-02-11 秦国忠 咖啡健神饮料
DK0815857T3 (da) * 1995-12-26 2005-01-24 Suntory Ltd Anti-adipöst middel indeholdende procyanidin som den aktive ingrediens
US6391310B1 (en) * 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
US6297273B1 (en) * 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
WO1998002165A1 (en) 1996-07-17 1998-01-22 Nutracorp Scientific, Inc. Appetite suppression
US5667793A (en) * 1996-08-02 1997-09-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions for treating cellulite
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans
FR2754709B1 (fr) * 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US20050245612A1 (en) * 2004-05-03 2005-11-03 Blass John P Pharmaceutical compositions for metabolic insufficiencies
WO1999034675A1 (en) 1998-01-07 1999-07-15 Nutracorp Scientific, Inc. Promoting mobilization and catabolism of lipids
EP1106073B1 (en) 1998-06-18 2008-08-20 Meiji Seika Kaisha, Ltd. Cocoa powder rich in polyphenols, process for producing the same and modified cocoa containing the same
US20030206981A1 (en) * 1999-04-15 2003-11-06 Lotte Confectionery Co., Ltd. Methods of using and compositions comprising cacao extract including dietary fiber
US6174542B1 (en) * 1999-07-01 2001-01-16 Pms Mood Food, Inc. Dietary supplements and food products for treating symptoms of PMS
US20010041675A1 (en) * 2000-01-24 2001-11-15 Jacobs Robert H. Satisfy composition and method of weight control
BRPI0108957B1 (pt) * 2000-03-10 2016-05-17 Yakult Honsha Kk inibidores da atividade da a-amilase
FR2810242B1 (fr) * 2000-06-16 2003-01-17 Nuxe Lab Composition cosmetique et/ou dermatologique a base d'extraits de cacao
FR2812873B1 (fr) 2000-08-11 2003-08-01 Barry Callebaut France Procede de production de polyphenols a partir de feves de cacao
JP2002173435A (ja) 2000-09-26 2002-06-21 Ryuei Soken:Kk 抗肥満剤および当該抗肥満剤の投与方法
AR033593A1 (es) * 2000-11-21 2003-12-26 Nestle Sa Una albumina de cacao recientemente identificada y su utilizacion en la produccion de sabor a cacao y chocolate
US6420350B1 (en) * 2001-01-18 2002-07-16 Goen Group, Inc. Weight loss product
US20020172732A1 (en) * 2001-03-21 2002-11-21 Wies Ter Laak Composition comprising cocoa
JP2002272376A (ja) * 2001-03-21 2002-09-24 Yuji Dokin チョコレート等の食料品
US20020192308A1 (en) * 2001-06-14 2002-12-19 John Mamana Method and composition for controlling weight
US7514107B2 (en) 2002-03-21 2009-04-07 Mars, Incorporated Treatment of diseases involving defective gap junctional communication
DE60225250D1 (de) 2002-05-29 2008-04-10 Sugar Company S P A In Forma A Nahrungsmittelzusammensetzungen auf der Basis von mit Intensivsüssstoff vermischtem Kakao und deren Herstellungsverfahren
KR100531472B1 (ko) * 2002-08-09 2005-11-28 주식회사 이롬 항산화 활성을 가지는 찔레나무 추출물을 포함하는 화장품 조성물 및 상기 추출물의 제조방법
US7585523B2 (en) * 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
US20050037025A1 (en) * 2002-10-03 2005-02-17 Gow Robert T. Methods and compositions comprising kava and mate' or theobromine
CA2518658A1 (en) * 2003-03-14 2004-09-30 Pro-Health, Inc. Composition and method for appetite and craving suppression and mood enhancement
DE10315025A1 (de) 2003-04-02 2004-10-14 Bioplanta Arzneimittel Gmbh Wirkstoffkombination von ω3-fettsäurehaltigen Ölen mit polyphenolhaltigen Pflanzenextrakten und deren Verwendung
US20050181083A1 (en) * 2003-04-18 2005-08-18 Toyo Shinyaku Co., Ltd. Diet food product
EP1648403B1 (en) 2003-05-20 2012-08-15 Sederma Slimming cosmetic composition comprising cafestol or kahweol
CN1938015A (zh) * 2004-01-28 2007-03-28 马尔斯公司 A型矢车菊苷配基的组合物和使用方法
WO2005074962A1 (ja) * 2004-02-10 2005-08-18 Asahi Breweries, Ltd. 筋張力増強剤
US20050277657A1 (en) 2004-06-15 2005-12-15 Dusan Ninkov Method of protection of biologically active essential oils and pharmaceutical composition for weight control and enhance fat burning in adults, adolescents and children
US20060057228A1 (en) * 2004-07-09 2006-03-16 Pure World Botanicals, Inc. Weight loss composition
FR2879448B1 (fr) 2004-12-17 2007-01-26 Oreal Composition amincissante comprenant une base xanthique, un dimethicone copolyol et une poudre de polyurethane
US20060134230A1 (en) * 2004-12-17 2006-06-22 Sal Abraham Weight loss composition and formulation
US20060182825A1 (en) 2005-02-11 2006-08-17 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods and compounds for the treatment of obesity and obesity-related disorders
US20060204599A1 (en) * 2005-03-14 2006-09-14 Wheat Jared R Dietary supplement and method of using same
US20060210653A1 (en) * 2005-03-18 2006-09-21 Gardiner Paul T Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition
FR2885050B1 (fr) * 2005-04-29 2008-09-05 Nuxe Sa Lab Composition amincissante a base d'extraits de cacao.
FR2885299B1 (fr) 2005-05-03 2009-11-20 Nuxe Lab Utilisation de polyphenols de cacao pour reguler la pigmentation de la peau
FR2885297B1 (fr) 2005-05-04 2007-07-20 Nuxe Sa Lab Nouvelle utilisation de polyphenols de cacao pour la regulation de cycle cellulaire.
CA2608865C (en) 2005-06-03 2015-08-25 Horizon Science Pty Ltd Molasses extract having body mass redistribution properties
AU2006257660A1 (en) * 2005-06-17 2006-12-21 Smartburn Formulations Ltd. Diet supplement comprising Hoodia Gordonii for weight loss and mental well-being
JP2009501161A (ja) * 2005-06-29 2009-01-15 マース インコーポレーテッド 血管系の健康改善に有用な熱処理されたカカオ製品
GB0520917D0 (en) 2005-10-14 2005-11-23 Zumbe Albert Chocolate based appetite suppressant
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
US8945652B2 (en) * 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
WO2007063563A1 (en) 2005-12-02 2007-06-07 Amedei S.R.L. Foofstuff based on cocoa and dehydrated fruit
WO2007076006A2 (en) * 2005-12-23 2007-07-05 Mars, Incorporated Skin protection and improvement
CA2637236A1 (en) 2006-01-17 2007-07-26 Barry Callebaut Ag Use of cacao polyphenols in beer production
US20070178176A1 (en) * 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss
AU2007258335B2 (en) * 2006-06-15 2013-11-14 Mars Incorporated Methods and compositions for improving cognitive function
FR2904773B1 (fr) * 2006-08-11 2008-11-07 Lvmh Rech Composition cosmetique amincissante contenant un extrait de biomasse de l'algue neochloris oleoabundans
GB0719545D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Novel use of cocoa extract
GB0719542D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Use of cocoa extract

Also Published As

Publication number Publication date
JP2010526036A (ja) 2010-07-29
GB0719544D0 (en) 2007-11-14
WO2008131911A1 (en) 2008-11-06
EP2142203A1 (en) 2010-01-13
US20100189829A1 (en) 2010-07-29
US8597692B2 (en) 2013-12-03

Similar Documents

Publication Publication Date Title
JP5432122B2 (ja) カカオ抽出物の使用
JP5450383B2 (ja) カカオ抽出物の使用
JP5432123B2 (ja) カカオ抽出物の新規な使用
DE60212117T2 (de) Neue schokoladenzusammensetzung als abgabesystem für nährstoffe und medikamente
Farah Nutritional and health effects of coffee
US20180104299A1 (en) Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a satiation agent for the treatment of obesity
KR20080030633A (ko) 스트레스의 치료 또는 처치방법
JP5557744B2 (ja) 皮膚効果をもたらすのに用いられるカカオ抽出物
JP2012025718A (ja) 経口毛穴改善剤
CA2863880A1 (en) Eucommia ulmoides-containing chocolate compositions
US20100040713A1 (en) Fat absorption inhibitor and food and drink using the same
JP6127545B2 (ja) ガレート型カテキンとタンパク質との複合体およびカフェインを含む抗肥満組成物の製造方法
KR102561297B1 (ko) 새싹보리 및 천연물질을 유효성분으로 함유하는 발모 촉진용 조성물
US20230380439A1 (en) Ready to eat chewable coffee tablets
JP2007070263A (ja) 糖尿病予防用組成物
JP2007070265A (ja) 脂質代謝改善用組成物
HK1143087B (en) Cocoa extract for use in improving skin health
JP2007070266A (ja) 血糖値上昇抑制剤
HK1132457B (en) Fat absorption inhibitor and food and drink using the same

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110420

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110420

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130604

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130702

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130925

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131002

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131024

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20131119

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131205

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees